HTL Biotechnology is betting €15m on salmon-derived DNA. Can regenerative medicine justify the expansion?
HTL Biotechnology opens its €15m HTL8 polynucleotide unit in France. See how the investment supports regenerative medicine manufacturing.
Pharma & Biotech